Human p63 (TP63) activation kit by CRISPRa
CAT#: GA105712
TP63 CRISPRa kit - CRISPR gene activation of human tumor protein p63
Find the corresponding CRISPRi Inhibitor Kit
USD 1,290.00
2 Weeks*
Specifications
Product Data | |
Format | 3gRNAs, 1 scramble ctrl and 1 enhancer vector |
Symbol | TP63 |
Locus ID | 8626 |
Kit Components | GA105712G1, TP63 gRNA vector 1 in pCas-Guide-CRISPRa GA105712G2, TP63 gRNA vector 2 in pCas-Guide-CRISPRa GA105712G3, TP63 gRNA vector 3 in pCas-Guide-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100058 |
Disclaimer | The kit is designed based on the best knowledge of CRISPa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc. |
Reference Data | |
RefSeq | NM_001114978, NM_001114979, NM_001114980, NM_001114981, NM_001114982, NM_001329144, NM_001329145, NM_001329146, NM_001329148, NM_001329149, NM_001329150, NM_001329964, NM_003722 |
Synonyms | AIS; B(p51A); B(p51B); EEC3; KET; LMS; NBP; OFC8; p40; p51; p53CP; p63; p73H; p73L; RHS; SHFM4 |
Summary | This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN208013 | TP63 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN208013BN | TP63 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN208013LP | TP63 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN208013RB | TP63 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN408013 | TP63 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
USD 1,290.00 |
{0} Product Review(s)
Be the first one to submit a review